Evidence map›Paper›PMID 28951487›Full record

ArticleEndocrine connections2017

Familial MTC with

Katerina Saltiki, Elli Anagnostou, George Simeakis, Sofia Kouki, Anastasia Angelopoulou, Leda Sarika, Alexandra Papathoma, Maria Alevizaki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endocrine connections, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Katerina SaltikiEndocrine UnitDepartment of Medical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece saze@otenet.gr.
Elli AnagnostouEndocrine UnitDepartment of Medical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
George SimeakisEndocrine UnitDepartment of Medical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
Sofia KoukiEndocrine UnitDepartment of Medical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
Anastasia AngelopoulouEndocrine UnitDepartment of Medical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
Leda SarikaEndocrine UnitDepartment of Medical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
Alexandra PapathomaEndocrine UnitDepartment of Medical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
Maria AlevizakiEndocrine UnitDepartment of Medical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
Alexandra Hospital · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHigh prevalence of

methods102 fMTC (FMTC and MEN2A) patients (31.4% males) were followed for 2.9-37 years (median 6 years). Fifty-one carried the

resultsExon 8 fMTC were older (42.3 ± 13.3 vs 30.8 ± 17.8 years,

conclusionsIn exon 8 fMTCs' older age, favorable disease stage at diagnosis and favorable outcome suggest slow disease progression compared to non-exon 8 fMTC. Compared with moderate-risk

Indexed as

exon 8Gly533Cysmedullary thyroid cancerMTCpapillary coexistencePTCRETsecond malignancy

Identifiers

PMID28951487
PMCPMC5655672
OpenAlexW2760155327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.